Inovio Pharmaceuticals saw the highest growth of 159% in patent filings in February and 99% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 70% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of Inovio Pharmaceuticals‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Inovio Pharmaceuticals has been focused on protecting inventions in United States(US) with seven publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 17% filings and 24% grants. The European Patent Office(EPO), United States(US), South Korea(KR), and Australia(AU) patent Office are among the top ten patent offices where Inovio Pharmaceuticals is filings its patents. Among the top granted patent authorities, Inovio Pharmaceuticals has 24% of its grants in United States(US), 18% in South Korea(KR) and 12% in Australia(AU).

GSK could be the strongest competitor for Inovio Pharmaceuticals

In terms of grant share, Inovio Pharmaceuticals stands in sixth position among its competitors. Inovio Pharmaceuticals and GSK secured the top positions according to recent patent publication data.

Patents related to rare diseases and Covid-19 lead Inovio Pharmaceuticals's portfolio

Inovio Pharmaceuticals has the highest number of patents in rare diseases followed by, Covid-19 and climate change. For rare diseases, nearly 42% of patents were filed and 14% of patents were granted in Q1 2024.

Severe acute respiratory syndrome (sars) related patents lead Inovio Pharmaceuticals portfolio followed by general surgery devices, and automobile batteries

Inovio Pharmaceuticals has highest number of patents in severe acute respiratory syndrome (sars) followed by general surgery devices, automobile batteries, zika virus infections, and ebolavirus infections (ebola hemorrhagic fever).

For comprehensive analysis of Inovio Pharmaceuticals's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.